RAPS Highlights

 

 

 

 

20 January 2022 | By Joanne S. Eglovitch
European Parliament endorses legislation bolstering EU’s ability to tackle shortages

The European Parliament approved legislation to increase the powers of the European Medicines Agency (EMA) in monitoring and respond...

20 January 2022 | By Joanne S. Eglovitch
Recon: 27 firms to manufacture Merck’s COVID pill; Blood sample collection tubes land on FDA device shortage list

Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.

20 January 2022 | By Joanne S. Eglovitch
FDA offers examples of innovative study designs accepted into CID pilot

The US Food and Drug Administration (FDA) recently highlighted three case studies showing how sponsors can incorporate innovative st...

20 January 2022 | By Nick Paul Taylor
Euro Roundup: MHRA seeks feedback on proposals for the future of UK clinical trial legislation

The Medicines and Healthcare products Regulatory Agency (MHRA) is holding a consultation into the future of clinical trial legislati...

19 January 2022 | By Renee Matthews
FDA Approvals Roundup: Ryaltris, Cibinqo, Rinvoq

A weekly update on new drug approvals and indications from the US Food and Drug Administration (FDA).